Clinical trials
Retinitis Pigmentosa trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2015 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 4 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 6 |
| Completed | 3 |
| Unknown status | 3 |
| Not yet recruiting | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Zhongshan Ophthalmic Center, Sun Yat-sen University | 3 |
| Sun Yat-sen University | 2 |
| Chigenovo Co., Ltd | 1 |
| Eye & ENT Hospital of Fudan University | 1 |
| Eyecure Therapeutics Inc. | 1 |
| National Eye Institute (NEI) | 1 |
| Peking University Third Hospital | 1 |
| Qi Zhou | 1 |
| Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 1 |
| Suzhou UgeneX Therapeutics Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Retinitis Pigmentosa | 15 |
| Diabetic Retinopathy | 2 |
| Retinal Diseases | 2 |
| Cataract | 1 |
| Central Serous Chorioretinopathy | 1 |
| Epiretinal Membrane | 1 |
| Glaucoma | 1 |
| Leber Congenital Amaurosis | 1 |
| Macular Degeneration | 1 |
| Ocular Hypertension | 1 |
Trials
Showing 51 to 15 of 15. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.